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Aim: Chronic obstructive pulmonary disease (COPD) is a common disease with increasing prevalence and mortality. We aimed to
determine COPD prevalence in primary health care centers.
Materials and methods: Pulmonary function tests (PFTs) and face-to-face interviews were administered to 500 patients older than 40
years of age and attending a primary health care center with any symptoms. An early reversibility test was performed on patients with a
forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio below 70%. The survey results, PFTs, and early reversibility test
results were evaluated according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. All parameters were
compared for groups with and without COPD.
Results: COPD was diagnosed in 25 (5%) of the patients. Of these patients, 60% were female and 40% were male. According to GOLD
guidelines, 48% of the patients had mild COPD, 36% of them had moderate COPD, and 16% of them had severe COPD. According to
their history and physical examination, 72 (14.4%) participants had been previously suspected of having COPD. PFTs revealed that 59
of them did not have COPD.
Conclusion: The utilization of spirometers in primary health care centers is important both for early diagnosis and to prevent
misdiagnosis of COPD.
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1. Introduction
Chronic obstructive pulmonary disease (COPD) is a major
health problem all over the world (1). It is important to
recognize and diagnose COPD early because appropriate
management can prevent and decrease symptoms, reduce
the frequency and severity of exacerbations, and improve
health status. Today, however, only 25% of patients with
COPD are diagnosed by health care centers (2). Spirometry
is recommended for the diagnosis and management of
COPD. Under-use or lack of spirometry devices makes it
difficult to diagnose the disease at an early stage.
Most COPD patients have a smoking history of 20
pack-years before the onset of symptoms, and they present
to a hospital at around 50 years of age because of respiratory
symptoms. The main symptoms of COPD include dyspnea,
cough, and sputum production. In addition, wheezy
breathing can be observed. There is a weak relationship
between the severity of symptoms and lung functions
of COPD patients (3). They may be asymptomatic in
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the early stages of the disease. Early diagnosis of the
disease, elimination of the etiologic factors, and effective
symptomatic treatment are important for improving the
quality of life in COPD patients (4,5).
In this study, we aimed to determine the prevalence of
COPD and investigate the accuracy of COPD diagnosis
due to history and physical examination findings alone,
using a questionnaire and spirometry in patients above 40
years old, with any symptoms, that had been admitted to a
primary health care center.
2. Materials and method
This study was conducted in a district of Erzurum,
Dadaşkent, with 15,000 inhabitants. The research was
carried out in the Dadaşkent Primary Health Care Center
(DPHCC). The approximate population of those over 40
years old in Dadaşkent district is 5,000. The daily number
of outpatients ranges from 200 to 250, and 30% of the
patients admitted to the daily clinic are over 40 years
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old. The study population consisted of 500 people (196
males, 304 females) older than 40 years of age who were
admitted to the DPHCC. The aim and plan of the study
were explained to the participants by their physician.
Patient confidentiality was maintained according to the
guidelines established by the Local Ethics Committee of
Atatürk University’s Faculty of Medicine, which approved
the study. Patients’ informed consents were received. The
height and weight of those who agreed to participate were
measured. A 13-item questionnaire about demographic
data, respiratory symptoms, smoking habits, previous
respiratory diseases, and occupational exposure was
answered by the participants.
In the study, a portable, rechargeable spirometer was
used (MIR Medical International Research, Rome, Italy).
Pulmonary function tests (PFTs) were performed. The
best forced vital capacity (FVC), forced expiratory volume
in 1 s (FEV1), and FEV1/FVC results were recorded.
According to Global Initiative for Chronic Obstructive
Lung Disease (GOLD) criteria, 400 µg of salbutamol
was inhaled by individuals who had obstruction in the
airways and the spirometric test was repeated after 20
min. Reversibility criteria were determined as an increase
in FEV1 (≥12%) and an increase in absolute FEV1 (>200
mL) after the administration of a bronchodilator agent. All
of these measurements were carried out by the physician
conducting the study. The doctor’s diagnosis was defined
by history plus physical examination. All parameters were
compared for the groups with and without a previous
diagnosis of COPD.

The demographic data of the patients and the PFT
results were evaluated using SPSS 11.0 for Windows (SPSS
Inc., Chicago, IL, USA). The difference between groups
was tested using the t-test. For the analysis of categorical
variables the chi-square test was used. Statistical difference
was considered significant if the P-value was less than 0.05.
3. Results
A total of 500 patients, 304 females (60.8%) and 196 males
(39.2%) with an average age of 55 ± 11 years and mean
body-mass index of 28.5 ± 5, were included the study. Of
these patients, 198 (39.6%) had a smoking history and 116
(23.2%) had biomass exposure. The patients’ risk factors
are shown in the Table. Among COPD patients, 9 (36%)
patients were nonsmokers, and 16 (64%) patients had a
history of smoking. Among female patients with COPD
(8 patients), biomass exposure was a more prominent risk
factor than smoking.
Doctors had previously suspected 72 participants
(14.4%) of having COPD. Of these, 59 were misdiagnosed.
There were no patients with an obstructive disease that had
reversibility according to the defined criteria. There were 48
patients using drugs against COPD. Figure 1 summarizes
the prevalence of COPD as assessed by spirometric
evaluation according to GOLD criteria. Of 25 patients
with COPD (5%), COPD had been previously diagnosed
in 13 patients (51.8%) and 11 were on medication. There
were 12 newly diagnosed COPD patients, 8 females and 4
males. Prevalence was greater in women than in men (60%
vs. 40%).

Table. Comparison of patients with and without COPD in terms of some risk factors.
FEV1/ FVC
Risk factors

<70

≥70

Total

Number (%)

Number (%)

Number (%)

P

Female

15 (5)

289 (95)

304 (60.8)

0.9

Male

10 (5)

186 (95)

196 (39.2)

No

9 (2.9)

293 (97)

302 (60.4)

Yes

16 (8)

182 (92)

198 (39.6)

No

17 (3.4)

367 (73.4)

384 (76.8)

Yes

8 (1.6)

108 (21.6)

116 (23.2)

No

24 (5.2)

436 (95)

460 (92)

Yes

1 (2.5)

39 (98)

40 (8)

Sex

Smoking habit
0.01

Biomass exposure
0.8

Occupational exposure
0.4
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83.2%
(n = 416)
Not diagnosed before the
study
Diagnosed before the
study

2.4%
(n = 12)

11.8%
(n = 59)

2.6%
(n = 13)

FEV1/FVC<70

FEV1/FVC ≥ 70

Figure 1. The evaluation of pulmonary function tests according
to diagnosis of COPD before study.

Before the study, 4 patients were already diagnosed with
severe COPD. Among newly diagnosed COPD patients,
mild COPD was the type most frequently detected (Figure
2).
In the COPD group, only 1 patient (4%) had no
respiratory complaints and 1 patient (4%) had only 1
symptom. Other patients had at least 2 symptoms.
4. Discussion
In our study, 25 patients (5%) were diagnosed with
COPD using spirometric measurements. Among those 25
patients, 12 patients (48.6%) were newly diagnosed. Before
the study, 72 patients (14.4%) had been diagnosed with
COPD, but 59 of them were misdiagnosed. These findings
suggest the importance of the use of spirometry, both for
early diagnosis and to avoid misdiagnosis. COPD is among
the highest-incidence diseases in the world. According to
data from the World Health Organization, COPD is the
fourth leading cause of death worldwide, and in 2020 it is
Diagnosed before the study
Not diagnosed before the study
34%
(n = 3)

56%
(n = 6)
100
(n = 4)

66%
(n = 8)

Mild

44%
(n = 4)

Moderate

Severe

Figure 2. Classification of COPD patients with regard to severity
of the disease.
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expected to become the third most common cause of death.
Unfortunately, sufficient epidemiologic data on COPD are
lacking in Turkey, but COPD prevalence, morbidity, and
mortality are all thought to be higher than was previously
estimated. Although smoking is very common in Turkey,
spirometric tests are not the basis for diagnosis of COPD
as applied in primary health care centers. Thus, this results
in serious deficiencies in the diagnosis and treatment of
the disease.
Spirometry administered by trained individuals is
required for early diagnosis and differential diagnosis
of COPD. The availability of spirometers in primary
health care is important. The calculation of prevalence
of COPD depends on population studies and diagnostic
methods. Expert opinion, a doctor’s diagnosis, respiratory
symptoms, and spirometric measurements to show the air
flow limitation are important techniques for identification
of the disease. Studies based on doctor diagnosis (6) have
the lowest prevalence, whereas those based on the presence
of respiratory symptoms (7) have the highest prevalence.
However, the prevalence based on spirometry lies between
the results of these 2 other approaches (8). The sensitivity
and specificity of the estimate based on the parameters
such as symptoms, patient history, and doctor’s diagnosis
are limited. Therefore, this study was planned to determine
air flow limitation with the use of spirometry.
If the asymptomatic early stage of the disease becomes
symptomatic, it reflects a severe loss of lung function and
marks the progression of the disease. Proper training and
use of spirometry reduces the misdiagnosis of COPD in
the primary care center and allows early diagnosis. In
our study, 72 participants (14.4%) had been previously
suspected to have COPD by the doctor. However, only 13
of them had proof of airway obstruction upon spirometry.
This shows that, without use of spirometry, COPD
diagnosis is overestimated. On the other hand, studies
in high risk groups have shown that use of spirometry
increases the number of patients diagnosed with COPD
(9–11). Thus, the widespread use of PFTs in the diagnosis
of COPD as well as the postgraduate training programs
that are proposed by the guidelines are important in order
to reduce physician factors in the diagnosis of COPD (12).
COPD is often misdiagnosed (10). The first reason for
this is that there are a significant number of physicians who
are not interested in the risk factors and symptoms of COPD
(6). Secondly, patients tend to adapt to the insidious onset
of COPD symptoms, seeking medical advice only when
the symptoms are aggravated or affecting their quality of
life (8). In our study population, among those with COPD,
only 1 (4%) did not have any symptoms, whereas all other
patients had at least 1 respiratory symptom. Early attempts
to quit smoking are required to encourage lung function
in COPD patients. In our study, most patients newly
diagnosed with COPD were smokers. Early diagnosis
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increases the overall impact of the warnings about the
hazards of smoking and may be a more effective alert than
the more abstract target of “quitting smoking” (13,14).
Approximately 50% of COPD patients have significant
symptoms (9–11). In our group, there was only 1 patient
who had no symptoms, while the remaining patients had 1
or more respiratory symptoms.
A review performed by Halbert et al. (15) showed that
in 16 of 32 studies, the prevalence of COPD was found
to be significant. In different parts of the world, these 16
studies reported prevalences of COPD ranging from 4% to
10%. In the DPHCC, COPD prevalence in patients over 40
years was consistent with international COPD prevalence
estimates given by Halbert et al. (15). Because our work
was a cross-sectional study, we did not compare our results
to the prevalence estimate. Moreover, we did not have any
subject with stage 4 COPD, unlike other studies (16,17).
These patients probably need therapy and should be
followed in secondary and tertiary care units.

Multiple risk factors such as smoking, occupational
exposure, air pollution, and biomass exposure can lead
to the development of COPD. In our patients with and
without COPD, only smoking was a risk factor, which has
been shown to be the most important risk factor in the
development of COPD (18). Smoking is responsible for
90% of COPD cases in developing countries (18). Smoking
is prevalent in Turkey and is a major public health problem
(19). In the Burden of Obstructive Lung Disease (BOLD)
study conducted in the province of Adana (20) on patients
with COPD, it was reported that only 12.3% of patients
received treatment for COPD and that 48.1% were still
smokers. In the present survey, among patients older than
40 years admitted to the DPHCC, 17.4% of women and
74% of men were smokers.
In conclusion, primary care physicians should have
adequate training and should be equipped with spirometric
instruments for the accurate and early diagnosis of COPD,
as well as for effective treatment initiation.
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